BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12744839)

  • 1. PerleCan fix your muscle AChEs.
    Steen MS; Froehner SC
    Trends Neurosci; 2003 May; 26(5):241-2. PubMed ID: 12744839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan.
    Peng HB; Xie H; Rossi SG; Rotundo RL
    J Cell Biol; 1999 May; 145(4):911-21. PubMed ID: 10330416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting acetylcholinesterase to the neuromuscular synapse.
    Rotundo RL; Rossi SG; Kimbell LM; Ruiz C; Marrero E
    Chem Biol Interact; 2005 Dec; 157-158():15-21. PubMed ID: 16289417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction.
    Peng HB; Ali AA; Daggett DF; Rauvala H; Hassell JR; Smalheiser NR
    Cell Adhes Commun; 1998 Sep; 5(6):475-89. PubMed ID: 9791728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane.
    Jacobson C; Côté PD; Rossi SG; Rotundo RL; Carbonetto S
    J Cell Biol; 2001 Feb; 152(3):435-50. PubMed ID: 11157973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction.
    Cartaud A; Strochlic L; Guerra M; Blanchard B; Lambergeon M; Krejci E; Cartaud J; Legay C
    J Cell Biol; 2004 May; 165(4):505-15. PubMed ID: 15159418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional organization of synaptic acetylcholinesterase.
    Aldunate R; Casar JC; Brandan E; Inestrosa NC
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):96-104. PubMed ID: 15572165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice.
    Arikawa-Hirasawa E; Rossi SG; Rotundo RL; Yamada Y
    Nat Neurosci; 2002 Feb; 5(2):119-23. PubMed ID: 11802174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmembrane mechanisms in the assembly of the postsynaptic apparatus at the neuromuscular junction.
    Geng L; Qian YK; Madhavan R; Peng HB
    Chem Biol Interact; 2008 Sep; 175(1-3):108-12. PubMed ID: 18513712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterases and the basal lamina at vertebrate neuromuscular junctions.
    Massoulié J; Millard CB
    Curr Opin Pharmacol; 2009 Jun; 9(3):316-25. PubMed ID: 19423392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice.
    Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J
    Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphoregulation by acetylcholinesterase in fibroblasts and astrocytes.
    Anderson AA; Ushakov DS; Ferenczi MA; Mori R; Martin P; Saffell JL
    J Cell Physiol; 2008 Apr; 215(1):82-100. PubMed ID: 17948252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dynamics of dystroglycan.
    Chamberlain J
    Nat Genet; 1999 Nov; 23(3):256-8. PubMed ID: 10545934
    [No Abstract]   [Full Text] [Related]  

  • 14. C-terminal and heparin-binding domains of collagenic tail subunit are both essential for anchoring acetylcholinesterase at the synapse.
    Kimbell LM; Ohno K; Engel AG; Rotundo RL
    J Biol Chem; 2004 Mar; 279(12):10997-1005. PubMed ID: 14702351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dystroglycan overexpression in vivo alters acetylcholine receptor aggregation at the neuromuscular junction.
    Heathcote RD; Ekman JM; Campbell KP; Godfrey EW
    Dev Biol; 2000 Nov; 227(2):595-605. PubMed ID: 11071777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct localization of collagen Q and PRiMA forms of acetylcholinesterase at the neuromuscular junction.
    Bernard V; Girard E; Hrabovska A; Camp S; Taylor P; Plaud B; Krejci E
    Mol Cell Neurosci; 2011 Jan; 46(1):272-81. PubMed ID: 20883790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct roles for dystroglycan, beta1 integrin and perlecan in cell surface laminin organization.
    Henry MD; Satz JS; Brakebusch C; Costell M; Gustafsson E; Fässler R; Campbell KP
    J Cell Sci; 2001 Mar; 114(Pt 6):1137-44. PubMed ID: 11228157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin-glycoprotein complex: molecular organization and critical roles in skeletal muscle.
    Sunada Y; Campbell KP
    Curr Opin Neurol; 1995 Oct; 8(5):379-84. PubMed ID: 8542044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase mobility and stability at the neuromuscular junction of living mice.
    Martinez-Pena y Valenzuela I; Akaaboune M
    Mol Biol Cell; 2007 Aug; 18(8):2904-11. PubMed ID: 17538015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synaptic form of acetylcholinesterase binds to cell-surface heparan sulfate proteoglycans.
    Brandan E; Inestrosa NC
    J Neurosci Res; 1986; 15(2):185-96. PubMed ID: 2937928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.